【摘要】 目的:探讨沙利度胺联合MP方案治疗多发性骨髓瘤的疗效。方法:对应用沙利度胺联合MP治疗的32例患者的临床资料进行回顾性分析。结果:初治病例32例给予沙利度胺联合MP方案治疗,总有效率为81.2%。结论:沙利度胺联合MP方案治疗初治多发性骨髓瘤具有缓解率优于以往的常规MP方案治疗,且副作用少,耐受性好,疗效确切。更多还原

【Abstract】 Objective:To discuss the clinical efficacy of thalidomide combined with MP in patients with multiple myeloma.Methods:Clinical data of 32 patients with newly diagnosed multiple myelom treated by thalidomide combined with MP was analyzed retrospectively.Results:All 32 patients with newly diagnosed multiple myeloma were treated by thalidomide combined with MP,the total effective rate was 81.2%.Conclusion:Thalidomide combined with MP in the treatment of newly diagnosed multiple myelom is better than that of conventional therapy scheme(MP),and with less side effects,good tolerance.更多还原